Introduction

The Right to Refuse Experimental Treatment protects an individual’s freedom to decline medical treatment that is still under investigation or has not been established as standard medical care. Experimental treatment may include unapproved medicines, investigational drugs, clinical-trial procedures, gene therapies, or new surgical and neurological interventions.

In India, this right is not separately codified as an independent fundamental right. Its constitutional foundation is primarily derived from Article 21, which protects life, personal liberty, dignity, and bodily autonomy. It is also connected with informed consent, medical ethics, and the right to make personal healthcare decisions.

The principle recognises that medical progress cannot justify forcing a competent person to undergo an experimental procedure. A patient must generally be informed about the treatment’s experimental nature, potential risks, possible benefits, and available alternatives before consenting. Equally, the patient should ordinarily be free to refuse or withdraw from participation in a clinical trial, subject to applicable legal and ethical safeguards.

Important Case Laws

1. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court held that medical consent must be real and valid. The patient must be competent, consent voluntarily, and receive adequate information about the nature, purpose, benefits, risks, alternatives, and consequences of refusing treatment.

The Court also held that a doctor cannot ordinarily perform an additional procedure without consent, except where an emergency makes it necessary to save life or preserve health and obtaining consent is impracticable. This case establishes the foundation for refusing experimental treatment: a patient’s permission for one procedure cannot automatically be treated as permission for an unapproved or experimental intervention.

VoxJuris+1

2. Common Cause v. Union of India (2018) 5 SCC 1

The Supreme Court recognised that a competent adult has the right to refuse medical treatment under Article 21. It affirmed the importance of autonomy, bodily integrity, and advance medical directives in specified end-of-life circumstances.

Although the judgment principally concerns refusal of life-sustaining treatment, its reasoning supports the principle that a competent patient should not ordinarily be forced to undergo medical intervention against their wishes.

VoxJuris

3. Yash Charitable Trust v. Union of India (2026) 2026 INSC 96

The Supreme Court considered the use of stem-cell interventions for autism spectrum disorder (ASD). It held that patients cannot demand a scientifically unvalidated treatment as a matter of right merely because they are willing to consent. Valid consent requires adequate information, including reliable knowledge about the treatment’s nature, benefits, risks, and alternatives.

The Court distinguished the freedom to accept or refuse treatment from an entitlement to demand any desired procedure. It also emphasised stronger consent safeguards for experimental therapies and recognised that participation in an approved and regulated clinical trial remains possible.

Sci API+1

Legal Framework and Scope

The right to refuse experimental treatment is supported by informed-consent requirements under Indian medical and clinical-trial regulation. Clinical trials generally require prior Ethics Committee approval and freely given informed consent. Participants are ordinarily entitled to withdraw without their medical care or legal rights being adversely affected.

ClinRegs+1

The doctrine includes the following principles:

Voluntary refusal: A competent adult may ordinarily decline an experimental procedure without coercion.

Informed decision-making: The patient must be told that the treatment is experimental, along with known risks, uncertainties, alternatives, and potential benefits.

Right to withdraw: A participant may ordinarily leave a clinical trial without penalty or loss of ordinary medical care.

Protection from exploitation: Researchers must not misrepresent experimental treatment as established or guaranteed therapy.

Emergency exception: Where a patient cannot consent and urgent intervention is necessary to save life, treatment may be justified under the principle of necessity, subject to applicable law.

Conclusion

The Right to Refuse Experimental Treatment protects bodily integrity, personal autonomy, and informed medical decision-making. Indian law provides a strong foundation through Samira Kohli, Common Cause, and the recent decision in Yash Charitable Trust. These cases establish that consent must be voluntary and informed, and that medical autonomy does not create an unconditional right to demand an unproven procedure.

The central principle is that medical progress cannot justify coercion, and a patient’s consent must be based on adequate information rather than false hope or incomplete disclosure. A lawful research framework must therefore preserve the freedom to refuse, provide safeguards for trial participants, and ensure that experimental interventions remain subject to scientific and ethical oversight.